Demographic and clinical characteristics of patients included in the study (Table S1); OTUs and coverage for the sequences obtained from gastric mucosal biopsy samples of 24 patients (Table S2); percentages of bacterial phyla found in the gastric mucosal biopsies from two groups of patients with dyspepsia (Table S3); detection of Helicobacter sequences by 454 pyrosequencing analysis and their relative abundances in gastric mucosal samples from the 24 patients, who did or did not receive proton pump inhibitors (Table S4); Adonis comparison of gastric bacterial community compositions for patient groups included in the study (Table S5); rarefaction curves of the 24 gastric biopsy samples studied (Fig. S1); results of the studies shown in Fig. 4 (Fig. S2) and Fig. 5 (Fig. S3) that were obtained after Helicobacter sequences were omitted from the analyses.
PDF, 742K